In Vivo PK/PD: Enhancing Drug Development

Kommentarer · 4 Visninger

The fields of pharmacokinetics (PK) and pharmacodynamics (PD) are crucial in drug discovery and development. PK involves the study of the processes by which a drug is absorbed, distributed, metabolized, and excreted in the body, while PD examines the effects of the drug on the body, includ

The fields of pharmacokinetics (PK) and pharmacodynamics (PD) are crucial in drug discovery and development. PK involves the study of the processes by which a drug is absorbed, distributed, metabolized, and excreted in the body, while PD examines the effects of the drug on the body, including the mechanisms of action and therapeutic outcomes. Understanding these processes is vital to optimizing drug candidates for clinical efficacy and safety.

Importance of In Vivo PK/PD Studies

For a drug to be effective, it must reach an adequate concentration in plasma and target tissues. This ensures the modulation of target proteins to achieve the desired therapeutic effect. Incorporating in vivo PK/PD studies at early stages of drug development markedly speeds up the identification of the most promising drug candidates. Such studies provide insights into dose-response relationships, the timing of drug effects, the extent of target modulation, and the identification of efficacious dosing regimens that maintain a therapeutic index.

In the evolving landscape of drug development, where complexity and costs are escalating, effective utilization of PK/PD data becomes paramount. It helps in weed out unsatisfactory drug candidates early in the process, enhancing the focus on those with the highest potential for clinical success.

Comprehensive Services Offered

Creative Bioarray offers an extensive range of services aimed at assessing in vivo PK/PD properties:

  • Development of standard and customized formulations
  • Conducting formulation screenings
  • Allometric dose predictions and PK optimization
  • Assessment of single, multiple, and cassette dosing in PK studies
  • Evaluating blood-brain barrier (BBB) penetration in various species
  • Analyzing whole blood-to-plasma partitioning
  • Stability studies in biological fluids
  • Tissue distribution assessments using traditional methods and quantitative whole-body autoradiography (QWBA)
  • Investigating entero-hepatic recirculation (EHC)
  • Assessing renal and biliary excretion dynamics

Species Availability

Our services are adaptable for numerous species including:

  • Mice
  • Rats
  • Hamsters
  • Guinea pigs
  • Rabbits
  • Beagles
  • Mini-pigs
  • Cynomolgus monkeys

Diverse Administration Routes

We accommodate various administration routes:

  • Oral (PO)
  • Intravenous (IV)
  • Intraarterial (IA)
  • Intramuscular (IM)
  • Intraperitoneal (IP)
  • Intratracheal (IT)
  • Subcutaneous (SC)
  • Transdermal (TD)
  • Intranasal (IN)
  • IV infusion
  • SC infusion
  • Rectal and topical delivery

Specialized Surgical Techniques

We employ specialized surgical methods such as:

  • Bile-duct cannulation (BDC)
  • Jugular cannulation (JVC)
  • Portal vein cannulation (PVC)
  • Carotid artery cannulation (CAC)

Comprehensive Sample Types

We analyze a vast array of sample types including:

  • Whole blood
  • Plasma
  • Serum
  • Bile
  • Feces
  • Urine
  • Cerebrospinal fluid
  • Various tissues

Features of Our Services

  • Facilities accredited by AAALAC, ensuring ethical treatment of animals across a variety of species.
  • Cutting-edge instruments and technologies for accurate and efficient data collection.
  • Expertise in PK model development and various in vivo techniques including surgical procedures and animal care.
  • Comprehensive formulation support and rigorous PK/PD data analysis, modeling, and simulation capabilities.
  • Assistance with regulatory documentation to facilitate timely progress through the regulatory landscape.

Effective PK/PD analysis is fundamental to drug development success. By understanding bioavailability, exposure levels, half-life, clearance rates, and metabolism, we can significantly influence a drug’s clinical trajectory. Creative Bioarray is committed to supporting drug discovery and preclinical development initiatives, leveraging our specialized knowledge and resources for small molecules, peptides, nucleosides, nucleotides, and biologics. Our dedication to excellence ensures that we collaborate with clients to design optimized study protocols best suited to their project needs.

Kommentarer